No Cover Image

Journal article 713 views 141 downloads

Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study

Julian Halcox Orcid Logo, José R. Banegas, Carine Roy, Jean Dallongeville, Guy De Backer, Eliseo Guallar, Joep Perk, David Hajage, Karin M. Henriksson, Claudio Borghi

BMC Cardiovascular Disorders, Volume: 17, Issue: 1

Swansea University Author: Julian Halcox Orcid Logo

  • Halcox-Pretreatmentofatherodys-EURIKA.pdf

    PDF | Version of Record

    This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/).

    Download (936.53KB)

Check full text

DOI (Published version): 10.1186/s12872-017-0591-5

Published in: BMC Cardiovascular Disorders
ISSN: 1471-2261
Published: 2017
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa34512
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2017-06-28T14:15:22Z
last_indexed 2018-02-09T05:24:43Z
id cronfa34512
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2017-07-31T14:02:54.0099054</datestamp><bib-version>v2</bib-version><id>34512</id><entry>2017-06-28</entry><title>Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study</title><swanseaauthors><author><sid>3676f695eeda169d0f8c618adf27c04b</sid><ORCID>0000-0001-6926-2947</ORCID><firstname>Julian</firstname><surname>Halcox</surname><name>Julian Halcox</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2017-06-28</date><deptcode>HDAT</deptcode><abstract/><type>Journal Article</type><journal>BMC Cardiovascular Disorders</journal><volume>17</volume><journalNumber>1</journalNumber><publisher/><issnElectronic>1471-2261</issnElectronic><keywords/><publishedDay>22</publishedDay><publishedMonth>6</publishedMonth><publishedYear>2017</publishedYear><publishedDate>2017-06-22</publishedDate><doi>10.1186/s12872-017-0591-5</doi><url/><notes/><college>COLLEGE NANME</college><department>Health Data Science</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>HDAT</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2017-07-31T14:02:54.0099054</lastEdited><Created>2017-06-28T12:58:33.4595055</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Julian</firstname><surname>Halcox</surname><orcid>0000-0001-6926-2947</orcid><order>1</order></author><author><firstname>Jos&#xE9; R.</firstname><surname>Banegas</surname><order>2</order></author><author><firstname>Carine</firstname><surname>Roy</surname><order>3</order></author><author><firstname>Jean</firstname><surname>Dallongeville</surname><order>4</order></author><author><firstname>Guy</firstname><surname>De Backer</surname><order>5</order></author><author><firstname>Eliseo</firstname><surname>Guallar</surname><order>6</order></author><author><firstname>Joep</firstname><surname>Perk</surname><order>7</order></author><author><firstname>David</firstname><surname>Hajage</surname><order>8</order></author><author><firstname>Karin M.</firstname><surname>Henriksson</surname><order>9</order></author><author><firstname>Claudio</firstname><surname>Borghi</surname><order>10</order></author></authors><documents><document><filename>0034512-28062017130624.pdf</filename><originalFilename>Halcox-Pretreatmentofatherodys-EURIKA.pdf</originalFilename><uploaded>2017-06-28T13:06:24.3500000</uploaded><type>Output</type><contentLength>969645</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><embargoDate>2017-06-28T00:00:00.0000000</embargoDate><documentNotes>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/).</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language></document></documents><OutputDurs/></rfc1807>
spelling 2017-07-31T14:02:54.0099054 v2 34512 2017-06-28 Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study 3676f695eeda169d0f8c618adf27c04b 0000-0001-6926-2947 Julian Halcox Julian Halcox true false 2017-06-28 HDAT Journal Article BMC Cardiovascular Disorders 17 1 1471-2261 22 6 2017 2017-06-22 10.1186/s12872-017-0591-5 COLLEGE NANME Health Data Science COLLEGE CODE HDAT Swansea University 2017-07-31T14:02:54.0099054 2017-06-28T12:58:33.4595055 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Julian Halcox 0000-0001-6926-2947 1 José R. Banegas 2 Carine Roy 3 Jean Dallongeville 4 Guy De Backer 5 Eliseo Guallar 6 Joep Perk 7 David Hajage 8 Karin M. Henriksson 9 Claudio Borghi 10 0034512-28062017130624.pdf Halcox-Pretreatmentofatherodys-EURIKA.pdf 2017-06-28T13:06:24.3500000 Output 969645 application/pdf Version of Record true 2017-06-28T00:00:00.0000000 This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/). true eng
title Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study
spellingShingle Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study
Julian Halcox
title_short Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study
title_full Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study
title_fullStr Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study
title_full_unstemmed Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study
title_sort Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study
author_id_str_mv 3676f695eeda169d0f8c618adf27c04b
author_id_fullname_str_mv 3676f695eeda169d0f8c618adf27c04b_***_Julian Halcox
author Julian Halcox
author2 Julian Halcox
José R. Banegas
Carine Roy
Jean Dallongeville
Guy De Backer
Eliseo Guallar
Joep Perk
David Hajage
Karin M. Henriksson
Claudio Borghi
format Journal article
container_title BMC Cardiovascular Disorders
container_volume 17
container_issue 1
publishDate 2017
institution Swansea University
issn 1471-2261
doi_str_mv 10.1186/s12872-017-0591-5
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine
document_store_str 1
active_str 0
published_date 2017-06-22T03:42:50Z
_version_ 1763751986492080128
score 11.013731

Similar Items